Literature DB >> 9001298

Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms.

D E O'Donnell1, J C Bertley, L K Chau, K A Webb.   

Abstract

We compared qualitative aspects of the sensory experience of exertional breathlessness in normal subjects and in patients with chronic airflow limitation (CAL) and sought a physiologic rationale for these. Twelve patients (66 +/- 2 yr of age, mean +/- SEM) with severe CAL (FEV1 = 37 +/- 5% predicted) and 12 age-matched normal subjects (FEV1 = 103 +/- 5% predicted) were studied. Perceived inspiratory difficulty (BorgIN), inspiratory effort (esophageal pressure expressed as a fraction of maximal esophageal pressure at isovolume [Pes/PImax]), breathing pattern, and operational lung volumes (end-expiratory/inspiratory lung volumes [EELV/EILV]) were measured during symptom-limited incremental cycle exercise testing and compared at a standard VO2 of 50% predicted maximum in normal subjects and in patients with CAL. Qualitative descriptors of breathlessness were selected immediately after exercise. Breathlessness was qualitatively different between normal subjects and patients with CAL. Both normal subjects and patients with CAL chose descriptors of increased "work/effort" and "heaviness" of breathing; however, only patients with CAL consistently chose descriptors denoting "increased inspiratory difficulty" (75%), "unsatisfied inspiratory effort" (75%), and "shallow breathing" (50%). Stepwise regression analysis identified the ratio of Pes/PImax to VT/predicted VC as the strongest correlate of standardized BorgIN (n = 24, r = 0.86, p < 0.001). This latter measurement, which reflects the relationship between effort and ventilatory output, correlated strongly with dynamic EELV/TLC at isotime (r = 0.78, p < 0.001). In conclusion, the qualitatively discrete respiratory sensations of exertional inspiratory difficulty peculiar to patients with CAL may have their origins in thoracic hyperinflation and the resultant disparity between inspiratory effort and ventilatory output.

Entities:  

Mesh:

Year:  1997        PMID: 9001298     DOI: 10.1164/ajrccm.155.1.9001298

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  70 in total

1.  Impaired adrenergic- and corticotropic-axis outflow during exercise in chronic obstructive pulmonary disease.

Authors:  Ali Iranmanesh; Dudley F Rochester; Jing Liu; Johannes D Veldhuis
Journal:  Metabolism       Date:  2011-05-31       Impact factor: 8.694

Review 2.  [Acute dyspnoea].

Authors:  U Wagner; C Vogelmeier
Journal:  Internist (Berl)       Date:  2005-09       Impact factor: 0.743

3.  Strengthening the Case for Cluster Set Resistance Training in Aged and Clinical Settings: Emerging Evidence, Proposed Benefits and Suggestions.

Authors:  Christopher Latella; Carolyn Peddle-McIntyre; Lauren Marcotte; James Steele; Kristina Kendall; Ciaran M Fairman
Journal:  Sports Med       Date:  2021-05-13       Impact factor: 11.136

4.  Extrinsic Threshold PEEP Reduces Post-exercise Dyspnea in COPD Patients: A Placebo-controlled, Double-blind Cross-over Study.

Authors:  A Daniel Martin; Paul W Davenport
Journal:  Cardiopulm Phys Ther J       Date:  2011-09

5.  Effects of ghrelin treatment on exertional dyspnea in COPD: an exploratory analysis.

Authors:  Keisuke Miki; Ryoji Maekura; Noritoshi Nagaya; Mari Miki; Seigo Kitada; Kenji Yoshimura; Masahide Mori; Kenji Kangawa
Journal:  J Physiol Sci       Date:  2015-02-28       Impact factor: 2.781

6.  Impact of pulmonary system limitations on locomotor muscle fatigue in patients with COPD.

Authors:  Markus Amann; Mark S Regan; Majd Kobitary; Marlowe W Eldridge; Urs Boutellier; David F Pegelow; Jerome A Dempsey
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05-05       Impact factor: 3.619

7.  Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; V N Maturu; Sahajal Dhooria; K T Prasad; Inderpaul S Sehgal; Lakshmikant B Yenge; Aditya Jindal; Navneet Singh; A G Ghoshal; G C Khilnani; J K Samaria; S N Gaur; D Behera
Journal:  Lung India       Date:  2013-07

Review 8.  [Heart and lungs : cardinal symptom dyspnea].

Authors:  M O Henke; C F Vogelmeier
Journal:  Herz       Date:  2013-05       Impact factor: 1.443

Review 9.  Is there any treatment other than drugs to alleviate dyspnea in COPD patients?

Authors:  Nicolino Ambrosino; Guido Vagheggini
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

Review 10.  Hyperinflation and its management in COPD.

Authors:  Luis Puente-Maestu; William W Stringer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.